138 related articles for article (PubMed ID: 3900470)
1. [Toxic hepatitis induced by cardiovascular agents].
Tanaka N; Matsushita E; Morimoto H; Kobayashi K; Hattori N
Nihon Rinsho; 1985 Jun; 43(6):1172-5. PubMed ID: 3900470
[No Abstract] [Full Text] [Related]
2. 'Intrahepatic cholestatic hepatitis following diagnostic ajmaline challenge'.
Mellor G; Fellows I; Williams I
Europace; 2013 Mar; 15(3):314. PubMed ID: 22804909
[No Abstract] [Full Text] [Related]
3. [Methyldopa-induced acute toxic hepatitis].
Fernández-Marcote Menor EM; Pérez-Bedmar Delgado J
Rev Esp Enferm Dig; 2005 Nov; 97(11):840-1. PubMed ID: 16438629
[No Abstract] [Full Text] [Related]
4. Alpha-methyldopa-induced acute hepatitis in pregnancy.
Phadnis SV; Sangay MR; Sanusi FA
Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):256-7. PubMed ID: 16704485
[No Abstract] [Full Text] [Related]
5. Hepatotoxicity of alpha-methyldopa in pregnancy.
Slim R; Ben Salem C; Hmouda H; Bouraoui K
J Clin Pharm Ther; 2010 Jun; 35(3):361-3. PubMed ID: 20831537
[TBL] [Abstract][Full Text] [Related]
6. [Adverse reactions to the main drugs used in cardiology].
Emerson F; Rios JB; Pereira LC
Arq Bras Cardiol; 1993 Aug; 61(2):111-8. PubMed ID: 8297220
[No Abstract] [Full Text] [Related]
7. [Side-effect of cardiovascular preparations on the eye].
Mozherenkov VP; Finkel'berg EI
Vestn Oftalmol; 1982; (3):67-9. PubMed ID: 7051511
[No Abstract] [Full Text] [Related]
8. Cholestatic hepatitis after diagnostic ajmaline challenge.
Hamoir C; Dano H; Komuta M; Druez P; Negrin Dastis S
Acta Gastroenterol Belg; 2017; 80(3):425-426. PubMed ID: 29560676
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular drugs and the elderly population.
Lapinski ML
Heart Lung; 1982; 11(5):430-4. PubMed ID: 6921190
[No Abstract] [Full Text] [Related]
10. Alpha-methyldopa hepatotoxicity in pregnancy.
Ali T; Srinivasan N; Le V; Rizvi S
J Coll Physicians Surg Pak; 2009 Feb; 19(2):125-6. PubMed ID: 19208320
[TBL] [Abstract][Full Text] [Related]
11. Special considerations in the use of cardiovascular drugs.
Ueland K; McAnulty JH; Ueland FR; Metcalfe J
Clin Obstet Gynecol; 1981 Sep; 24(3):809-23. PubMed ID: 7026105
[No Abstract] [Full Text] [Related]
12. Update of hepatotoxicity due to classes of drugs in common clinical use: non-steroidal drugs, anti-inflammatory drugs, antibiotics, antihypertensives, and cardiac and psychotropic agents.
Zimmerman HJ
Semin Liver Dis; 1990 Nov; 10(4):322-38. PubMed ID: 2281340
[No Abstract] [Full Text] [Related]
13. Neuropsychiatric sequelae of pharmacotherapy of cardiac arrhythmias and hypertension.
Lloyd BL; Greenblatt DJ
J Clin Psychopharmacol; 1981 Nov; 1(6):394-8. PubMed ID: 7334149
[No Abstract] [Full Text] [Related]
14. Adverse effects of cardiovascular drug therapy on the fetus and neonate.
Witter FR; King TM; Blake DA
Obstet Gynecol; 1981 Nov; 58(5 Suppl):100S-5S. PubMed ID: 7031536
[TBL] [Abstract][Full Text] [Related]
15. α-Methyldopa-induced hepatitis during the postpartum period.
Kashkooli S; Baraty B; Kalantar J
BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24577181
[TBL] [Abstract][Full Text] [Related]
16. [Ajmaline induced hepatitis in Denmark].
Rubinstein E; Dejgård A; Duus B
Ugeskr Laeger; 1981 Nov; 143(49):3304-5. PubMed ID: 7331043
[No Abstract] [Full Text] [Related]
17. [Problems of evaluating rare adverse drug reactions using as an example agranulocytosis induced by anti-arrhythmia agents].
Knipping W
Med Klin; 1980 Feb; 75(3):108-15. PubMed ID: 7374607
[No Abstract] [Full Text] [Related]
18. Severe hepatitis from methyldopa.
Maddrey WC; Boitnott JK
Gastroenterology; 1975 Feb; 68(2):351-60. PubMed ID: 22550758
[TBL] [Abstract][Full Text] [Related]
19. [Drug-induced severe jaundice].
Valhovd M; Kildahl-Andersen O
Tidsskr Nor Laegeforen; 2003 May; 123(9):1202-3. PubMed ID: 12789790
[No Abstract] [Full Text] [Related]
20. [The effect of cardiovascular agents on amino acid aryl amidase].
Mentz P; Schmidt R; Förster W
Pharmazie; 1973 Apr; 28(4):261-2. PubMed ID: 4716613
[No Abstract] [Full Text] [Related]
[Next] [New Search]
